Planning Committee

Beth Faiman, PHD, MSN, APN-BC, AOCN, BMTCN, FAAN

Nurse Practitioner

Department of Hematology and Medical Oncology Cleveland Clinic

Cleveland, OH

Beth Sandy, MSN, CRNP

Nurse Practitioner, Thoracic Medical Oncology

Abramson Cancer Center, University of Pennsylvania

Philadelphia, PA

Val R. Adams, PharmD, FCCP, FHOPA, BCOP

Associate Professor, Oncology Specialist

University of Kentucky

Lexington, KY

Leigh Ann Childress MSN, NP, AOCNP

Director of Advanced Practice 

Clearview Cancer Institute

Huntsville, AL

Danielle Roberts PA-C

Physician assistant with the Bone Marrow Transplant team 

Winship Cancer Institute of Emory University

Atlanta, GA

Faculty

Anthony J Olszanski, RPh, MD

Physician

Fox Chase Cancer Center

Philadelphia, PA

Alicia M. Rigby MSN, RN, APRN, AOCNP

Nurse Practitioner

UC Davis Cancer Center

Sacramento, CA

Tanya Uritsky PharmD, BCPP 

Opioid Stewardship Coordinator 

University of Pennsylvania (HUP)

Philadelphia, PA

Greata Russler, MSN, FNP-BC 

Nurse Practitioner

Winship Cancer Institute of Emory University

Atlanta, GA

Kathryn Green, CRNP, MSN

Nurse Practitioner

Abramson Cancer Center, University of Pennsylvania

Philadelphia, PA

Rachel Frankenthal, PA-C

Physician Assistant

UCLA Health

Los Angeles, CA

Jennie M. Goble, PA-C

Instructor in Medicine

 Mayo Clinic

 Rochester, MN

Marianne Davies, DNP, ACNP, AOCNP, FAAN

Nurse Practitioner

Yale-New Haven Yale Comprehensive Cancer Center

New Haven, CT

Suzanne McGettigan CRNP

Oncology Nurse Practitioner and Clinical Manager of Advanced Practice Providers and Nursing

Perelman Center for Advanced Medicine, Abramson Cancer Center

Philadelphia, PA

Bridget Harr CNP

Nurse Practitioner

Cleveland Clinic

Cleveland, OH

Taylor Aldridge

Physician Assistant

Standford Healthcare

Standford, CA

Vanessa Nevins, PA-C, RDMS, RT 

Physician Assistant

Yale New Haven Smilow Cancer Hospital

New Haven, CT

Krisin Daily, MSN, ANP-BC AOCNP

Nurse Practitioner

St. Louis School of Medicine

St. Louis, MO

Kayla Freeman, DNP, APRN, FNP-C  

Nurse Practitioner

Emory Winship Cancer Institute

Atlanta, GA

Lauren Imboden 

Physician Assistant

Atrium Health Wake Forest Baptist

Winston-Salem, NC

Amitkumar Mehta, MD

Physician

University of Alabama

Tuscaloosa, Alabama

Ann Katz, PhD, RN, FAAN, AASECT-Certified Sexuality Counselor

Nurse

CancerCare Manitoba

Winnipeg, Canada

Donna Catamero, ANP-BC, OCN, CCRC

Nurse Practitioner

Icahn School of Medicine at Mount Sinai Hospital

New York, NY

Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP

Clinical Oncology Pharmacist

University of Illinois College of Pharmacy

Chicago, IL

Amy Goodrich, RN, MSN, CRNP

Nurse Practitioner

Johns Hopkins

Baltimore, MD

Laura Wood, RN, MSN, OCN 

Nurse

Cleveland Clinic, Taussig Cancer Center

Cleveland, OH

Peter Hakos, PA-C

Physician Assistant

Cleveland Clinic

Cleveland, OH

Lisa Nodzon PhD, APRN, AOCNP

Nurse Practitioner

H. Lee Moffitt Cancer Center and Research Institute

Tampa, FL

Sujata Kane, MS, RD, PA-C

Nurse Practitioner

Winship Cancer Institute, Emory University

Atlanta, GA

DISCLOSURES:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous.

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

Planners

Those others involved in the planning of this activity disclosed no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Other Contributors

All other non-faculty contributors and others involved in the planning, development and editing/review of the content disclosed no relevant financial relationships with any entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients.

Faculty, Authors, and Content Developers Disclosures

• Anthony J. Olszanski, RPh, MD discloses advisory board with BMS, Merck, Pfizer, Novartis, Eisai, Nectar, InstillBio but these relationships have ended and contracted research with Alkermes, antegene, Elucida, Eutilex, GSK, HiFiBio, Immatics during the past 24 months.
• Suzanne McGettigan, CRNP discloses speaker’s bureau with BMS, Regeneron, Merck, Pfizer during the past 24 months.
• Beth Sandy, MSN, CRNP discloses speaker’s bureau with Merck Takeda, AstraZeneca, Jazz Amgen and advisory boards with Abbvie and Janssen during the past 24 months.  
• Greta Russler, MSN, FNP-BC discloses advisory boards with BMS during the past 24 months.
• Laura S. Wood, RN, MSN, OCN discloses speaker’s bureau with AVEO, BMS, Exelixis, EMD, Serono, Merck, Pfizer during the past 24 months.  
• Kristin M. Daly, MSN, ANP-BC, AOCNP discloses advisory boards with Eisai but this relationship has ended during the past 24 months.
• Kathryn L. Green, CRNP, MSN discloses speaker’s bureau with AstraZeneca and advisory boards with AadiBio during the past 24 months.
• Rachel Frankenthal, PA-C discloses advisory boards with Immunogen and GSK but these relationships have ended during the past 24 months.
• Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN discloses Advisory Board and Consulting Fee with Janssen, Sanofi, Karyopharm during the past 24 months.
• Donna Catamero, ANP-BC, OCN, CCRC discloses speaker’s bureau with speaker’s bureau with Johnson & Johnson, Bristol Myers Squibb, and advisory boards with Johnson and Johnson, Legend, Sanofi, Pfizer, BMS, and consulting fees with Johnson and Johnson during the past 24 months.
• Lisa Nodzon PhD, APRN, AOCNP discloses Speaker’s Bureau with Pharmacyclics AstraZeneca and Speaker’s Bureau with Takeda and Genentech/AbbVie but that relationship has ended.Advisory Board with BeiGene; Pharmacyclics, Novartis and Consulting Fee with AstraZeneca; AbbVie during the past 24 months.
• Amy Goodrich, RN, MSN, CRNP discloses advisory boards with Abbvie, AstraZeneca, BieGene, Fresenuis during the past 24 months.
• Peter Hakos, PA-C – discloses stock ownership with Pfizer and AbbVie during the past 24 months.
• Lauren Imboden, PA-C discloses advisory boards with Sanofi and Genzyme but this relationship has ended during the past 24 months.
• Amitkumar Mehta, MD discloses speaker’s bureau with Incyte/Morphosys, BeiGen, Ipsen, consulting fees with Gilead, Seattle Genetics, Incyte, and contracted research with Incyte, Takeda, forty-seven inc/Gilead during the past 24 months.

Planners:

• Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN discloses consulting fees with Amgen, BMS, Janssen, Pfizer, and Karyopharm during the past 24 months.
• Val R. Adams, PharmD, FCCP, FHOPA, BCOP discloses contracted research with BMS during the past 24 months.
• Beth Sandy, MSN, CRNP discloses advisory boards with Amgen, BMS, Janssen, Pfizer, Karyopharm, Abbvie, and Janssen during the past 24 months.
• Leigh Ann Childress, MSN, NP, AOCNP discloses speaker’s bureau with AstraZeneca, Seagen, Sobi, Merck, Amgen during the past 24 months.

Copyright Information:

Copyright© 2024 by Horizon CME. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from Horizon CME.